Latest filing published 06 Apr 2026 for 리센스메디컬.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- -27.7%Entry ₩23,600 · Close at T+90 ₩17,070
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Lb인베스트먼트: trading record in brief
Filings by Lb인베스트먼트 span 2 companies, the busiest being LB인베스트먼트 and 리센스메디컬. In total, 3 filings cover trades dated from 11 March 2025 to 31 March 2026.
Every open-market trade on record is a purchase: 1 purchase, and no sale. The amount is not disclosed for 1 filing. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2026 alone, the filings show 1 purchase and no sales.
The latest filing, published on 6 April 2026, reports an open-market purchase in 리센스메디컬. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Lb인베스트먼트
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 918,085 sharesKRXDART:20260406001188Canonical exit: 29 Jun 2026 (T+90)
3 of 3 declarations